Top

Social Psychiatry and Psychiatric Epidemiology

Published in:

01-10-2020 | Antidepressant Drugs | Review

Social inequalities in antidepressant treatment outcomes: a systematic review

Authors: Deeksha Elwadhi, Alex Cohen

Published in: Social Psychiatry and Psychiatric Epidemiology | Issue 10/2020

Abstract

Purpose

To identify, review and synthesize evidence on whether social disadvantage moderates antidepressant treatment outcomes, even when access to treatment is not a consideration.

Methods

The systematic review was done in accordance with PRIMSA guidelines. An a priori systematic search strategy was used to search databases (MEDLINE, PsychINFO, EMBASE, Global Health and Cochrane Trials Library) from their earliest entries through December 31, 2018. A two-step screening procedure was followed, and all experimental studies of antidepressant treatment in ICD/DSM diagnosed cases of depression were included. Studies with subjects < 18 years or investigating other modalities of treatment were excluded.

Results

Thirteen papers reporting analyses from nine studies met inclusion criteria. There was heterogeneity in sample sizes, target populations, treatment settings, clinical outcomes and definition of SES indices. The primary outcome was the relative effect of socioeconomic status (SES) (as measured by income, employment status and level of education)—on antidepressant treatment outcomes.

Conclusions

The evidence from this review suggests that lower SES may lead to social inequalities in antidepressant treatment outcomes even in the context of clinical trials in which all participants have equal access to the same high-quality, standardized care. The review calls for more careful consideration of the choice and operationalization of SES indicators, and the need to “employ sampling methods that ensure ample representation of individuals from a wide range of social worlds”. The review concludes with tentative suggestions about how to reduce social inequalities in antidepressant treatment outcomes at the level of individuals and populations.

Available only for authorised users

Hirschfeld RMA, Cross CK (1982) Epidemiology of affective disorders: psychosocial risk factors. Arch Gen Psychiatry 39(1):35–46. https://doi.org/10.1001/archpsyc.1982.04290010013003CrossRefPubMed

Perry MJ (1996) The relationship between social class and mental disorder. J Prim Prev 17(1):17–30. https://doi.org/10.1007/BF02262736CrossRefPubMed

Lorant V, Deliege D, Eaton W, Robert A, Philippot P, Ansseau M (2003) Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol 157(2):98–112. https://doi.org/10.1093/aje/kwf182CrossRefPubMed

Lund C, Breen A, Flisher AJ, Kakuma R, Corrigall J, Joska JA, Swartz L, Patel V (2010) Poverty and common mental disorders in low and middle income countries: a systematic review. Soc Sci Med 71(3):517–528. https://doi.org/10.1016/j.socscimed.2010.04.027CrossRefPubMedPubMedCentral

Kessler RC, Bromet EJ (2013) The epidemiology of depression across cultures. Annu Rev Public Health 34:119–138. https://doi.org/10.1146/annurev-publhealth-031912-114409CrossRefPubMedPubMedCentral

Murphy JM, Olivier DC, Monson RR, Sobol AM, Federman EB, Leighton AH (1991) Depression and anxiety in relation to social status: a prospective epidemiologic study. Arch Gen Psychiatry 48(3):223–229. https://doi.org/10.1001/archpsyc.1991.01810270035004CrossRefPubMed

Liu J, Yan F, Ma X, Guo HL, Tang YL, Rakofsky JJ, Wu XM, Li XQ, Zhu H, Guo XB, Yang Y, Li P, Cao XD, Li HY, Li ZB, Wang P, Xu QY (2015) Prevalence of major depressive disorder and socio-demographic correlates: Results of a representative household epidemiological survey in Beijing, China. J Affect Disord 179:74–81. https://doi.org/10.1016/j.jad.2015.03.009CrossRefPubMedPubMedCentral

Kleinberg A, Aluoja A, Vasar V (2010) Point prevalence of major depression in Estonia. Results from the 2006 estonian health survey. Eur Psychiatry 25(8):485–490. https://doi.org/10.1016/j.eurpsy.2010.06.005CrossRefPubMed

Jenkins R, Bhugra D, Bebbington P, Brugha T, Farrell M, Coid J, Fryers T, Weich S, Singleton N, Meltzer H (2008) Debt, income and mental disorder in the general population. Psychol Med 38(10):1485–1493. https://doi.org/10.1017/S0033291707002516CrossRefPubMed

10.

Kosidou K, Dalman C, Lundberg M, Hallqvist J, Isacsson G, Magnusson C (2011) Socioeconomic status and risk of psychological distress and depression in the Stockholm public health cohort: a population-based study. J Affect Disord 134(1–3):160–167. https://doi.org/10.1016/j.jad.2011.05.024CrossRefPubMed

11.

Freeman A, Tyrovolas S, Koyanagi A, Chatterji S, Leonardi M, Ayuso-Mateos JL, Tobiasz-Adamczyk B, Koskinen S, Rummel-Kluge C, Haro JM (2016) The role of socio-economic status in depression: results from the courage (aging survey in Europe). BMC Public Health 16(1):1098. https://doi.org/10.1186/s12889-016-3638-0CrossRefPubMedPubMedCentral

12.

Folb N, Lund C, Fairall LR, Timmerman V, Levitt NS, Steyn K, Bachmann MO (2015) Socioeconomic predictors and consequences of depression among primary care attenders with non-communicable diseases in the western cape, South Africa: cohort study within a randomised trial. BMC Public Health 15:1194. https://doi.org/10.1186/s12889-015-2509-4CrossRefPubMedPubMedCentral

13.

Wang JL, Schmitz N, Dewa CS (2010) Socioeconomic status and the risk of major depression: the canadian national population health survey. J Epidemiol Community Health 64(5):447–452. https://doi.org/10.1136/jech.2009.090910CrossRefPubMed

14.

Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) The epidemiology of major depressive disorder: results from the national comorbidity survey replication (ncs-r). JAMA 289(23):3095–3105. https://doi.org/10.1001/jama.289.23.3095CrossRefPubMed

15.

Beard JR, Tracy M, Vlahov D, Galea S (2008) Trajectory and socioeconomic predictors of depression in a prospective study of residents of New York city. Ann Epidemiol 18(3):235–243. https://doi.org/10.1016/j.annepidem.2007.10.004CrossRefPubMed

16.

Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF (2018) Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry 75(4):336–346. https://doi.org/10.1001/jamapsychiatry.2017.4602CrossRefPubMedPubMedCentral

17.

Sarren J, Afifi TO, McMillan KA, Asmundson GJG (2011) Relationship between household income and mental disorders: Findings from a population-based longitudinal study. Arch Gen Psychiatry 68:419–427CrossRef

18.

Arias-de la Torre J, Vilagut G, Martin V, Molina AJ, Alonso J (2018) Prevalence of major depressive disorder and association with personal and socio-economic factors. Results for spain of the European health interview survey 2014–2015. J Affect Disord 239:203–207. https://doi.org/10.1016/j.jad.2018.06.051CrossRefPubMed

19.

Andersen I, Thielen K, Nygaard E, Diderichsen F (2009) Social inequality in the prevalence of depressive disorders. J Epidemiol Community Health 63(7):575–581. https://doi.org/10.1136/jech.2008.082719CrossRefPubMed

20.

Wilhelm K, Mitchell P, Slade T, Brownhill S, Andrews G (2003) Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord 75(2):155–162. https://doi.org/10.1016/s0165-0327(02)00040-xCrossRefPubMed

21.

Murcia M, Chastang JF, Niedhammer I (2015) Educational inequalities in major depressive and generalized anxiety disorders: results from the French national sip study. Soc Psychiatry Psychiatr Epidemiol 50(6):919–928. https://doi.org/10.1007/s00127-015-1010-9CrossRefPubMed

22.

Zuelke AE, Luck T, Schroeter ML, Witte AV, Hinz A, Engel C, Enzenbach C, Zachariae S, Loeffler M, Thiery J, Villringer A, Riedel-Heller SG (2018) The association between unemployment and depression–results from the population-based life-adult-study. J Affect Disord 235:399–406. https://doi.org/10.1016/j.jad.2018.04.073CrossRefPubMed

23.

Blazer DG, Kessler RC, McGonagle KA, Swartz MS (1994) The prevalence and distribution of major depression in a national community sample: the national comorbidity survey. Am J Psychiatry 151(7):979–986. https://doi.org/10.1176/ajp.151.7.979CrossRefPubMed

24.

Mair C, Roux AVD, Galea S (2008) Are neighbourhood characteristics associated with depressive symptoms? A review of evidence. J Epidemiol Community Health 62(11):940–946. https://doi.org/10.1136/jech.2007.066605CrossRefPubMed

25.

Sampson L, Martins SS, Yu S, Chiavegatto Filho ADP, Andrade LH, Viana MC, Medina-Mora ME, Benjet C, Torres Y, Piazza M, Aguilar-Gaxiola S, Cia AH, Stagnaro JC, Zaslavsky AM, Kessler RC, Galea S (2019) The relationship between neighborhood-level socioeconomic characteristics and individual mental disorders in five cities in latin America: Multilevel models from the world mental health surveys. Soc Psychiatry Psychiatr Epidemiol 54(2):157–170. https://doi.org/10.1007/s00127-018-1595-xCrossRefPubMed

26.

Ostler K, Thompson C, Kinmonth AL, Peveler RC, Stevens L, Stevens A (2001) Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: The hampshire depression project. Br J Psychiatry 178(1):12–17CrossRefPubMed

27.

Generaal E, Timmermans EJ, Dekkers JEC, Smit JH, Penninx B (2019) Not urbanization level but socioeconomic, physical and social neighbourhood characteristics are associated with presence and severity of depressive and anxiety disorders. Psychol Med 49(1):149–161. https://doi.org/10.1017/S0033291718000612CrossRefPubMed

28.

Melchior M, Chastang JF, Leclerc A, Ribet C, Rouillon F (2010) Low socioeconomic position and depression persistence: longitudinal results from the GAZEL cohort study. Psychiatry Res 177(1–2):92–96. https://doi.org/10.1016/j.psychres.2009.08.002CrossRefPubMed

29.

Melchior M, Chastang JF, Head J, Goldberg M, Zins M, Nabi H, Younes N (2013) Socioeconomic position predicts long-term depression trajectory: a 13-year follow-up of the GAZEL cohort study. Mol Psychiatry 18(1):112–121. https://doi.org/10.1038/mp.2011.116CrossRefPubMed

30.

Almeida OP, Pirkis J, Kerse N, Sim M, Flicker L, Snowdon J, Draper B, Byrne G, Lautenschlager NT, Stocks N, Alfonso H, Pfaff JJ (2012) Socioeconomic disadvantage increases risk of prevalent and persistent depression in later life. J Affect Disord 138(3):322–331. https://doi.org/10.1016/j.jad.2012.01.021CrossRefPubMed

31.

Musliner KL, Munk-Olsen T, Eaton WW, Zandi PP (2016) Heterogeneity in long-term trajectories of depressive symptoms: patterns, predictors and outcomes. J Affect Disord 192:199–211. https://doi.org/10.1016/j.jad.2015.12.030CrossRefPubMed

32.

Green MJ, Benzeval M (2013) The development of socioeconomic inequalities in anxiety and depression symptoms over the lifecourse. Soc Psychiatry Psychiatr Epidemiol 48(12):1951–1961. https://doi.org/10.1007/s00127-013-0720-0CrossRefPubMedPubMedCentral

33.

Holden L, Harris M, Hockey R, Ferrari A, Lee YY, Dobson AJ, Lee C (2019) Predictors of change in depressive symptoms over time: results from the Australian longitudinal study on women's health. J Affect Disord 245:771–778. https://doi.org/10.1016/j.jad.2018.11.076CrossRefPubMed

34.

Olfson M, Marcus SC (2009) National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66(8):848–856. https://doi.org/10.1001/archgenpsychiatry.2009.81CrossRefPubMed

35.

Olfson M, Blanco C, Marcus SC (2016) Treatment of adult depression in the United States. JAMA Internal Med 176(10):1482–1491. https://doi.org/10.1001/jamainternmed.2016.5057CrossRef

36.

Kivimaki M, Gunnell D, Lawlor DA, Davey Smith G, Pentti J, Virtanen M, Elovainio M, Klaukka T, Vahtera J (2007) Social inequalities in antidepressant treatment and mortality: a longitudinal register study. Psychol Med 37(3):373–382. https://doi.org/10.1017/S0033291706009457CrossRefPubMed

37.

Olfson M, Mojtabai R, Sampson NA, Hwang I, Druss B, Wang PS, Wells KB, Pincus HA, Kessler RC (2009) Dropout from outpatient mental health care in the United States. Psychiatr Serv 60(7):898–907. https://doi.org/10.1176/appi.ps.60.7.898CrossRefPubMedPubMedCentral

38.

Bocquier A, Cortaredona S, Verdoux H, Casanova L, Sciortino V, Nauleau S, Verger P (2014) Social inequalities in early antidepressant discontinuation. Psychiatr Serv 65(5):618–625. https://doi.org/10.1176/appi.ps.201300184CrossRefPubMed

39.

Rojas-Garcia A, Ruiz-Perez I, Rodriguez-Barranco M, Goncalves Bradley DC, Pastor-Moreno G, Ricci-Cabello I (2015) Healthcare interventions for depression in low socioeconomic status populations: a systematic review and meta-analysis. Clin Psychol Rev 38:65–78. https://doi.org/10.1016/j.cpr.2015.03.001CrossRefPubMed

40.

Brown GW, Harris TO, Kendrick T, Chatwin J, Craig TK, Kelly V, Mander H, Ring A, Wallace V, Uher R, Thread Study Group (2010) Antidepressants, social adversity and outcome of depression in general practice. J Affect Disord 121(3):239–246. https://doi.org/10.1016/j.jad.2009.06.004CrossRefPubMed

41.

Kelly KM, Mezuk B (2017) Predictors of remission from generalized anxiety disorder and major depressive disorder. J Affect Disord 208:467–474. https://doi.org/10.1016/j.jad.2016.10.042CrossRefPubMed

42.

Miranda J, Chung JY, Green BL, Krupnick J, Siddique J, Revicki DA, Belin T (2003) Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA 290(1):57–65. https://doi.org/10.1001/jama.290.1.57CrossRefPubMed

43.

Araya R, Rojas G, Fritsch R, Gaete J, Rojas M, Simon G, Peters TJ (2003) Treating depression in primary care in low-income women in Santiago, Chile: a randomised controlled trial. Lancet 361(9362):995–1000CrossRefPubMed

44.

Areán PA, Gum AM, Tang L, Unutzer J (2007) Service use and outcomes among elderly persons with low incomes being treated for depression. Psychiatr Serv 58(8):1057–1064. https://doi.org/10.1176/appi.ps.58.8.1057CrossRefPubMed

45.

Dohrenwend BP, Dohrenwend BS (1969) Social status and psychological disorder: a causal inquiry. Wiley-Interscience, New York

46.

Dohrenwend BS (1973) Social status and stressful life events. J Pers Soc Psychol 28(2):225–235. https://doi.org/10.1037/h0035718CrossRefPubMed

47.

Pearlin LI (1989) The sociological study of stress. J Health Soc Behav 30(3):241–256. https://doi.org/10.2307/2136956CrossRefPubMed

48.

Rickels K (1968) Drug use in outpatient treatment. Am J Psychiatry 124(8):20–31. https://doi.org/10.1176/ajp.124.8S.20CrossRef

49.

Rickels K, Jenkins BW, Zamostien B, Raab E, Kanther M (1967) Pharmacotherapy in neurotic depression. Differential population responses. J Nerv Ment Dis 145(6):475–485. https://doi.org/10.1097/00005053-196712000-00005CrossRefPubMed

50.

Rickels K, Ward CH, Schut L (1964) Different populations, different drug responses. A comparative study of two anti-depressants, each used in two different patient groups. Am J Med Sci 247:328–335. https://doi.org/10.1097/00000441-196403000-00013CrossRefPubMed

51.

Downing RW, Rickels K (1973) Predictors of response to amitriptyline and placebo in three outpatient treatment settings. J Nerv Ment Dis 156(2):109–129. https://doi.org/10.1097/00005053-197302000-00004CrossRefPubMed

52.

Downing RW, Rickels K (1972) Predictors of amitriptyline response in outpatient depressives. J Nerv Ment Dis 154(4):248–263. https://doi.org/10.1097/00005053-197204000-00003CrossRefPubMed

53.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100CrossRefPubMedPubMedCentral

54.

Welch V, Petticrew M, Tugwell P, Moher D, O'Neill J, Waters E, White H, PRISMA-Equity Bellagio group (2012) PRISMA-equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med 9(10):e1001333. https://doi.org/10.1371/journal.pmed.1001333CrossRefPubMedPubMedCentral

55.

Welch V, Petticrew M, Petkovic J, Moher D, Waters E, White H, Tugwell P, Group PR-EB (2016) Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-e 2012): explanation and elaboration. J Clin Epidemiol 70(2):68–89. https://doi.org/10.1016/j.jclinepi.2015.09.001CrossRefPubMed

56.

Finegan M, Firth N, Wojnarowski C, Delgadillo J (2018) Associations between socioeconomic status and psychological therapy outcomes: a systematic review and meta-analysis. Depress Anxiety 35(6):560–573CrossRefPubMed

57.

Cochrane Collaboration (2017) Cochrane central register of controlled trials (central). https://www.cochranelibrary.com/central/about-central. Accessed 31 July 2018

58.

Balestri M, Calati R, Souery D, Kautzky A, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A (2016) Socio-demographic and clinical predictors of treatment resistant depression: a prospective European multicenter study. J Affect Disord 189:224–232. https://doi.org/10.1016/j.jad.2015.09.033CrossRefPubMed

59.

Cohen A, Gilman SE, Houck PR, Szanto K, Reynolds CF (2009) Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Soc Psychiatry Psychiatr Epidemiol 44(4):272–277. https://doi.org/10.1007/s00127-008-0436-8CrossRefPubMed

60.

Croughan JL, Secunda SK, Katz MM, Robins E, Mendels J, Swann A, Harris-Larkin B (1988) Sociodemographic and prior clinical course characteristics associated with treatment response in depressed patients. J Psychiatr Res 22(3):227–237. https://doi.org/10.1016/0022-3956(88)90008-8CrossRefPubMed

61.

Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ (1998) Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J Clin Psychiatry 59(12):669–675CrossRefPubMed

62.

Mrazek DA, Biernacka JM, McAlpine DE, Benitez J, Karpyak VM, Williams MD, Hall-Flavin DK, Netzel PJ, Passov V, Rohland BM, Shinozaki G, Hoberg AA, Snyder KA, Drews MS, Skime MK, Sagen JA, Schaid DJ, Weinshilboum R, Katzelnick DJ (2014) Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study. J Clin Psychopharmacol 34(3):313–317. https://doi.org/10.1097/JCP.0000000000000099CrossRefPubMedPubMedCentral

63.

Perlis RH, Alpert J, Nierenberg AA, Mischoulon D, Yeung A, Rosenbaum JF, Fava M (2003) Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day. Acta Psychiatr Scand 108(6):432–438. https://doi.org/10.1046/j.0001-690X.2003.00168.xCrossRefPubMed

64.

Zisook S, Johnson GR, Tal I, Hicks P, Chen P, Davis L, Thase M, Zhao Y, Vertrees J, Mohamed S (2019) General predictors and moderators of depression remission: a vast-d report. Am J Psychiatry 176(5):348–357. https://doi.org/10.1176/appi.ajp.2018.18091079CrossRefPubMed

65.

Bao Y, Alexopoulos GS, Casalino LP, Ten Have TR, Donohue JM, Post EP, Schackman BR, Bruce ML (2011) Collaborative depression care management and disparities in depression treatment and outcomes. Arch Gen Psychiatry 68(6):627–636. https://doi.org/10.1001/archgenpsychiatry.2011.55CrossRefPubMedPubMedCentral

66.

Gilman SE, Fitzmaurice GM, Bruce ML, Ten Have T, Glymour MM, Carliner H, Alexopoulos GS, Mulsant BH, Reynolds CF 3rd, Cohen A (2013) Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideation. Epidemiology 24(1):14–22. https://doi.org/10.1097/EDE.0b013e3182762403CrossRefPubMedPubMedCentral

67.

Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M, STAR*D Study Team (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163(1):28–40CrossRefPubMed

68.

Rush AJ, Wisniewski SR, Warden D, Luther JF, Davis LL, Fava M, Nierenberg AA, Trivedi MH (2008) Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Arch Gen Psychiatry 65(8):870–880. https://doi.org/10.1001/archpsyc.65.8.870CrossRefPubMed

69.

Friedman ES, Wisniewski SR, Gilmer W, Nierenberg AA, Rush AJ, Fava M, Zisook S, Balasubramani GK, Trivedi MH (2009) Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR*D trial. Depress Anxiety 26(7):612–621. https://doi.org/10.1002/da.20568CrossRefPubMed

70.

Jakubovski E, Bloch MH (2014) Prognostic subgroups for citalopram response in the STAR*D trial. J Clin Psychiatry 75(7):738–747. https://doi.org/10.4088/JCP.13m08727CrossRefPubMedPubMedCentral

71.

Vallejo J, Gasto C, Catalan R, Bulbena A, Menchon JM (1991) Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators. J Affect Disord 21(3):151–162CrossRefPubMed

72.

Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62. https://doi.org/10.1136/jnnp.23.1.56CrossRefPubMedPubMedCentral

73.

Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R (2003) The 16-item quick inventory of depressive symptomatology (qids), clinician rating (qids-c), and self-report (qids-sr): a psychometric evaluation in patients with chronic major depression. Biol Psychiat 54(5):573–583CrossRefPubMed

74.

Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389CrossRefPubMed

75.

Guy W (1976) Clinical global impressions scale Ecdeu assessment manual for psychopharmacology. US Dept Health, Education, and Welfare publication (AMD) 76 338:221–227

76.

Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L (2017) Systematic reviews of effectiveness. In: Aromataris E, Munn Z (eds) Joanna briggs institute reviewer's manual. The Joanna Briggs Institute, Adelaide

77.

Buajitti E, Chiodo S, Rosella LC (2020) Agreement between area- and individual-level income measures in a population-based cohort: implications for population health research. SSM Popul Health 10:100553. https://doi.org/10.1016/j.ssmph.2020.100553CrossRefPubMedPubMedCentral

78.

Pardo-Crespo MR, Narla NP, Williams AR, Beebe TJ, Sloan J, Yawn BP, Wheeler PH, Juhn YJ (2013) Comparison of individual-level versus area-level socioeconomic measures in assessing health outcomes of children in olmsted county, minnesota. J Epidemiol Community Health 67(4):305–310. https://doi.org/10.1136/jech-2012-201742CrossRefPubMed

79.

Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV (2005) Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: the public health disparities geocoding project. Am J Public Health 95(2):312–323. https://doi.org/10.2105/AJPH.2003.032482CrossRefPubMedPubMedCentral

80.

Krieger N (2006) A century of census tracts: Health & the body politic (1906–2006). J Urban Health 83(3):355–361. https://doi.org/10.1007/s11524-006-9040-yCrossRefPubMedPubMedCentral

81.

Diez Roux AV, Mair C (2010) Neighborhoods and health. Ann N Y Acad Sci 1186:125–145. https://doi.org/10.1111/j.1749-6632.2009.05333.xCrossRefPubMed

82.

Elovainio M, Vahtera J, Pentti J, Hakulinen C, Pulkki-Raback L, Lipsanen J, Virtanen M, Keltikangas-Jarvinen L, Kivimaki M, Kahonen M, Viikari J, Lehtimaki T, Raitakari O (2020) The contribution of neighborhood socioeconomic disadvantage on depressive symptoms over the adult lifetime: a 32-year prospective cohort study. Am J Epidemiol. https://doi.org/10.1093/aje/kwaa026CrossRefPubMedPubMedCentral

83.

Kim D (2008) Blues from the neighborhood? Neighborhood characteristics and depression. Epidemiol Rev 30(1):101–117. https://doi.org/10.1093/epirev/mxn009CrossRefPubMed

84.

Galea S, Ahern J, Nandi A, Tracy M, Beard J, Vlahov D (2007) Urban neighborhood poverty and the incidence of depression in a population-based cohort study. Ann Epidemiol 17(3):171–179. https://doi.org/10.1016/j.annepidem.2006.07.008CrossRefPubMedPubMedCentral

85.

Ross CE, Wu C-L (1995) The links between education and health. Am Sociol Rev 60(5):719–745CrossRef

86.

Galea S, Ahern J (2005) Distribution of education and population health: an ecological analysis of New York city neighborhoods. Am J Public Health 95(12):2198–2205CrossRefPubMedPubMedCentral

87.

Zajacova A, Lawrence EM (2018) The relationship between education and health: reducing disparities through a contextual approach. Annu Rev Public Health 39:273–289. https://doi.org/10.1146/annurev-publhealth-031816-044628CrossRefPubMedPubMedCentral

88.

Dudal P, Bracke P (2016) Absolute and relative educational inequalities in depression in Europe. Int J Public Health 61(7):787–795. https://doi.org/10.1007/s00038-016-0837-5CrossRefPubMed

89.

Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005) Twelve-month use of mental health services in the United States: results from the national comorbidity survey replication. Arch Gen Psychiatry 62(6):629–640CrossRefPubMed

90.

Alegria M, Bijl RV, Lin E, Walters EE, Kessler RC (2000) Income differences in persons seeking outpatient treatment for mental disorders: a comparison of the United States with Ontario and the Netherlands. Arch Gen Psychiatry 57(4):383–391CrossRefPubMed

91.

Dickman SL, Himmelstein DU, Woolhandler S (2017) Inequality and the health-care system in the USA. Lancet 389(10077):1431–1441. https://doi.org/10.1016/S0140-6736(17)30398-7CrossRefPubMed

92.

Carter KN, Blakely T, Collings S, Imlach Gunasekara F, Richardson K (2009) What is the association between wealth and mental health? J Epidemiol Community Health 63(February):221–226. https://doi.org/10.1136/jech.2008.079483CrossRefPubMed

93.

Pollack CE, Chideya S, Cubbin C, Williams B, Dekker M, Braveman P (2007) Should health studies measure wealth?: a systematic review. Am J Prev Med 33(3):250–264. https://doi.org/10.1016/j.amepre.2007.04.033CrossRefPubMed

94.

Braveman P, Egerter S, Williams DR (2011) The social determinants of health: coming of age. Annu Rev Public Health 32(1):381–398. https://doi.org/10.1146/annurev-publhealth-031210-101218CrossRefPubMed

95.

Porru F, Burdorf A, Robroek SJW (2018) The impact of depressive symptoms on exit from paid employment in Europe: a longitudinal study with 4 years follow-up. Eur J Public Health 29(1):134–139. https://doi.org/10.1093/eurpub/cky136CrossRefPubMedCentral

96.

Whooley MA, Kiefe CI, Chesney MA, Markovitz JH, Matthews K, Hulley SB (2002) Depressive symptoms, unemployment, and loss of income: the cardia study. Arch Intern Med 162(22):2614–2620. https://doi.org/10.1001/archinte.162.22.2614CrossRefPubMed

97.

Dooley D, Catalano R, Wilson G (1994) Depression and unemployment: panel findings from the epidemiologic catchment area study. Am J Community Psychol 22(6):745–765. https://doi.org/10.1007/BF02521557CrossRefPubMed

98.

Burgard SA, Brand JE, House JS (2007) Toward a better estimation of the effect of job loss on health. J Health Soc Behav 48(4):369–384. https://doi.org/10.1177/002214650704800403CrossRefPubMed

99.

Warden D, Rush AJ, Wisniewski SR, Lesser IM, Thase ME, Balasubramani GK, Shores-Wilson K, Nierenberg AA, Trivedi MH (2009) Income and attrition in the treatment of depression: a STAR*D report. Depress Anxiety 26(7):622–633. https://doi.org/10.1002/da.20541CrossRefPubMed

100.

Araya R, Lewis G, Rojas G, Fritsch R (2003) Education and income: Which is more important for mental health? J Epidemiol Community Health 57(7):501–505CrossRefPubMedPubMedCentral

101.

Gilman SE, Bruce ML, Ten Have T, Alexopoulos GS, Mulsant BH, Reynolds CF 3rd, Cohen A (2013) Social inequalities in depression and suicidal ideation among older primary care patients. Soc Psychiatry Psychiatr Epidemiol 48(1):59–69. https://doi.org/10.1007/s00127-012-0575-9CrossRefPubMed

102.

Finegan M, Firth N, Delgadillo J (2020) Adverse impact of neighbourhood socioeconomic deprivation on psychological treatment outcomes: the role of area-level income and crime. Psychother Res 30(4):546–554. https://doi.org/10.1080/10503307.2019.1649500CrossRefPubMed

103.

Silva M, Loureiro A, Cardoso G (2016) Social determinants of mental health: a review of the evidence. Eur J Psychiatry 30:259–292

104.

Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, Posner S (2005) Socioeconomic status in health research: one size does not fit all. JAMA 294(22):2879–2888CrossRefPubMed

105.

Polo AJ, Makol BA, Castro AS, Colon-Quintana N, Wagstaff AE, Guo S (2019) Diversity in randomized clinical trials of depression: a 36-year review. Clin Psychol Rev 67:22–35. https://doi.org/10.1016/j.cpr.2018.09.004CrossRefPubMed

106.

Iosifescu DV, Bankier B, Fava M (2004) Impact of medical comorbid disease on antidepressant treatment of major depressive disorder. Curr Psychiatry Rep 6(3):193–201. https://doi.org/10.1007/s11920-004-0064-2CrossRefPubMed

107.

Thase ME (2016) Managing medical comorbidities in patients with depression to improve prognosis. J Clin Psychiatry 77(Suppl 1):22–27. https://doi.org/10.4088/JCP.14077su1c.04CrossRefPubMed

108.

WHO, Calouste Gulbenkian Foundation (2014) Social determinants of mental health. World Health Organization, Geneva

109.

Katon WJ, Lin EHB, Von Korff M, Ciechanowski P, Ludman EJ, Young B, Peterson D, Rutter CM, McGregor M, McCulloch D (2010) Collaborative care for patients with depression and chronic illnesses. NEJM 363(27):2611–2620. https://doi.org/10.1056/NEJMoa1003955CrossRefPubMed

110.

Braveman P, Gottlieb L (2014) The social determinants of health: It's time to consider the causes of the causes. Public Health Rep 129(Suppl 2):19–31CrossRefPubMedPubMedCentral

111.

Pollack MH (2005) Comorbid anxiety and depression. J Clin Psychiatry 66:22–29CrossRefPubMed

112.

Miranda J, Azocar F, Organista KC, Dwyer E, Areane P (2003) Treatment of depression among impoverished primary care patients from ethnic minority groups. Psychiatr Serv 54(2):219–225CrossRefPubMed

113.

Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Mendlewicz J, Group for the Study of Resistant Depression (2007) Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. J Clin Psychiatry 68(7):1062–1070CrossRefPubMed

114.

Bruce ML, Ten Have TR, Reynolds CF 3rd, Katz II, Schulberg HC, Mulsant BH, Brown GK, McAvay GJ, Pearson JL, Alexopoulos GS (2004) Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 291(9):1081–1091. https://doi.org/10.1001/jama.291.9.1081CrossRefPubMed

115.

Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G (2004) Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 25(1):119–142CrossRefPubMed

Title: Social inequalities in antidepressant treatment outcomes: a systematic review
Authors: Deeksha Elwadhi
Alex Cohen
Publication date: 01-10-2020
Publisher: Springer Berlin Heidelberg
Keywords: Antidepressant Drugs
Mood Disorders
Affective Disorder
Antidepressant Drugs
Published in: Social Psychiatry and Psychiatric Epidemiology / Issue 10/2020
Print ISSN: 0933-7954
Electronic ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-020-01918-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Social inequalities in antidepressant treatment outcomes: a systematic review

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2020

Health, social and criminal justice factors associated with dual diagnosis among incarcerated adults in Brazil and Australia: a cross-national comparison

Cohort profile: Epidemiology and Genetics of Obsessive–compulsive disorder and chronic tic disorders in Sweden (EGOS)

English use/proficiency, ethnic discrimination, and alcohol use disorder in Hispanic immigrants

Network structure of depression symptomology in participants with and without depressive disorder: the population-based Health 2000–2011 study

New antidepressant utilization pre- and post-bereavement: a population-based study of partners and adult children

Association of response rate and prevalence estimates of common mental disorders across 129 areas in a nationally representative survey of adults in Japan